Latest Articles

Long-term Safety and Efficacy of Avalglucosidase Alfa IN Patients with Late-Onset Pompe Disease (NEO-EXT)

Safety and efficacy of Avalglucosidase Alfa versus Alglucosidase Alfa in patints with Late-Onset Pompe Disease (COMET): a phase 3, randomized, multicentral study results

Nirsevimab RWD Metanalysis

Nirsevimab Metanalysis Real world data

Decoding OX40L: A Key Player in Atopic Dermatitis Pathways

Chronic Spontaneous Urticaria is an Immune-Mediated Inflammatory Skin Disease

EoE Pathophysiology

Type 2 Inflammation in the Pathophysiology of the Lower Airways

The Role of the CNS and Periphery in MS and Disease Accumulation

Epidemiology

Epidemiology